The DESappear Study: Drug Eluting Scaffold

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

August 28, 2018

Study Completion Date

April 30, 2021

Conditions
Peripheral Vascular Disease
Interventions
DEVICE

Akesys Prava Scaffold

Implantation of the Akesys Prava Sirolimus Eluting Bioresorbable Peripheral Scaffold System

Trial Locations (11)

1140

Hanusch Hospital, Vienna

49808

Bonifatius Hospital, Lingen

59759

Klinikum Arnsberg, Arnsberg

A8036

LKH University Hospital Graz, Graz

Unknown

AZ Sint Blasius, Dendermonde, Dendermonde

Heilig Hart Hospital, Tienen

Heart Center Bad Krozingen, Freiburg im Breisgau

Universitätsklinikum Leipzig AöR,, Leipzig

St Franziskus Hospital, Münster

Auckland City Hospital, Auckland

Wellington Hospital, Wellington

Sponsors

Collaborators (1)

All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

collaborator

Syntactx

NETWORK

collaborator

Massachusetts General Hospital

OTHER

collaborator

Genae

INDUSTRY

NCT02869087 - The DESappear Study: Drug Eluting Scaffold | Biotech Hunter | Biotech Hunter